Home / Resource Library / Patients with lymphoma treated with B-cell-depleting therapies may have worse outcomes from COVID-19 infection

Patients with lymphoma treated with B-cell-depleting therapies may have worse outcomes from COVID-19 infection

AACR 2021: Results of a study examining outcomes of COVID-19 patients with lymphoma undergoing treatment.